Rockwell Medical (RMTI) Return on Capital Employed Growth (3y) (2014 - 2026)
Rockwell Medical (RMTI) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | 1,036.00 |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | 175.00 |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 120.00 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 434.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -295.00 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1,076.00 |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 1,898.00 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Rockwell Medical | 29.87 Mn | 5.07 Mn | 3.24 Mn | 3,627.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,627.00 |
| Mar 31, 2026 | 3,052.00 |
| Dec 31, 2025 | 4,146.00 |
| Sep 30, 2025 | 5,153.00 |
| Jun 30, 2025 | 8,585.00 |
| Mar 31, 2025 | 12,847.00 |
| Dec 31, 2024 | 9,423.00 |
| Sep 30, 2024 | 7,762.00 |
| Jun 30, 2024 | 8,315.00 |
| Mar 31, 2024 | 2,618.00 |
| Dec 31, 2023 | 2,271.00 |
| Sep 30, 2023 | 1,305.00 |
| Jun 30, 2023 | 1,049.00 |
| Mar 31, 2023 | 3,933.00 |
| Dec 31, 2022 | 5,077.00 |
| Sep 30, 2022 | 2,883.00 |
| Jun 30, 2022 | -64.00 |
| Mar 31, 2022 | -2,547.00 |
| Dec 31, 2021 | 815.00 |
| Sep 30, 2021 | 4,290.00 |